Companies / Oncology Institute, Inc.

Oncology Institute, Inc.

Nasdaq: TOICIK 1799191CERRITOS, CA

Financials · FY2025

Revenue$502.73M
Net income$-60.61M
Total debt$80.05M
Cash$200.0K
Diluted EPS$-0.54
Shares outstanding101.9M

Ownership

101.9M shares outstanding · as of Jul 30, 2026
2.2%Insiders
Ownership
Insiders2.21%2,256,471
10%+ / strategic10.28%10,479,358
Public float87.50%89,180,286

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 6

View all →
Insider% of sharesShares
10.28%10,479,358
Virnich DanielCEOChief Executive Officer
1.75%1,788,150
Podnos YaleChief Medical Officer
0.23%234,510
Carter Robert RossChief Financial Officer
0.23%233,811
Stolper MarkDirector

Institutional holders 0

HolderValue% of shares
No institutional holders on file.

Activity

InsidersInstitutions
Who's accumulating and trimming this stock (13F).
No activity matches these filters.

5%+ ownership events

Schedule 13D / 13G
FilerStance% of classSharesDate
Chernett JoreyPassive13G/A
Chernett JoreyPassive13G5,114,944

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
TOI23343Q100